+318.0%
CORZ vs MRNA
+124.2%
+193.8%
-64.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.3% | -7.0% | +5.7% | -1.0% |
| 7D | +26.4% | -4.2% | +30.5% | +26.6% |
| 30D | -6.8% | +7.0% | -13.8% | -7.2% |
| 3M | -31.1% | +263.4% | -294.5% | -37.4% |
| 6M | -36.9% | +334.3% | -371.2% | -45.4% |
| YTD | -1.2% | +684.5% | -685.7% | -23.6% |
| 1Y | -12.5% | +766.2% | -778.7% | -33.5% |
| All | +318.0% | +124.2% | +193.8% | +260.7% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling